Advertisement

Local Anesthetics and Adjuvants

  • Francesco Vetri
  • Jose A. Aguirre
  • Effrossyni G. Votta-Velis
  • Alain Borgeat
Chapter

Abstract

Local anesthetics are the pharmacologic cornerstone of regional anesthesia producing reversible and complete blockade of neuronal transmission when applied near the axons. Their application results in complete interruption of nerve impulse conduction, allowing abolition of sensation from the area innervated by the corresponding nerves and leading also to motor block.

Keywords

Local anesthetics Local anesthetic adjuvants Local anesthetic toxicity Local anesthetic mechanism of action Bupivacaine Ropivacaine Mepivacaine Lidocaine Peripheral nerve block 

References

  1. 1.
    van der Wal SE, van den Heuvel SA, Radema SA, van Berkum BF, et al. The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain. Eur J Pain. 2016;20(5):655–74.CrossRefPubMedGoogle Scholar
  2. 2.
    Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology. 2000;93(3):858–75.CrossRefPubMedGoogle Scholar
  3. 3.
    Piegeler T, Votta-Velis EG, Liu G, Place AT, Schwartz DE, Beck-Schimmer B, Minshall RD, Borgeat A. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology. 2012;117(3):548–59.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Nguyen HM, Goldin AL. Sodium channel carboxyl-terminal residue regulates fast inactivation. J Biol Chem. 2010;285:9077–89.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Goldberg YP, MacFarlane J, MacDonald ML, Thompson J, Dube MP, Mattice M, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet. 2007;71:311–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Yarov-Yarovoy V, Brown J, Sharp EM, Clare JJ, Scheuer T, Catterall WA. Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J Biol Chem. 2001;276:20–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Huang JH, Thalhammer JG, Raymond SA, Strichartz GR. Susceptibility to lidocaine of impulses in different somatosensory afferent fibers of rat sciatic nerve. J Pharmacol Exp Ther. 1997;282:802–11.PubMedGoogle Scholar
  8. 8.
    Ilfeld BM, Moeller LK, Mariano ER, Loland VJ, Stevens-Lapsley JE, Fleisher AS, et al. Continuous peripheral nerve blocks: is local anesthetic dose the only factor, or do concentration and volume influence infusion effects as well? Anesthesiology. 2010;112:347–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Ashchi M, Wiedemann HP, James KB. Cardiac complication from use of cocaine and phenylephrine in nasal septoplasty. Arch Otolaryngol Head Neck Surg. 1995;121:681–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Le Truong HH, Girard M, Drolet P, Grenier Y, Boucher C, Bergeron L. Spinal anesthesia: a comparison of procaine and lidocaine. Can J Anaesth. 2001;48:470–3.CrossRefPubMedGoogle Scholar
  11. 11.
    Hodgson PS, Neal JM, Pollock JE, Liu SS. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg. 1999;88:797–809.CrossRefPubMedGoogle Scholar
  12. 12.
    Duque S, Fernandez L. Delayed-type hypersensitivity to amide local anesthetics. Allergol Immunopathol (Madr). 2004;32:233–4.CrossRefGoogle Scholar
  13. 13.
    Meffin P, Long GJ, Thomas J. Clearance and metabolism of mepivacaine in the human neonate. Clin Pharmacol Ther. 1973;14:218–25.CrossRefPubMedGoogle Scholar
  14. 14.
    Gristwood RW. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine. Drug Saf. 2002;25:153–63.CrossRefPubMedGoogle Scholar
  15. 15.
    Mather LE, Chang DH. Cardiotoxicity with modern local anaesthetics: is there a safer choice? Drugs. 2001;61:333–42.CrossRefPubMedGoogle Scholar
  16. 16.
    Casati A, Putzu M. Bupivacaine, levobupivacaine and ropivacaine: are they clinically different? Best Pract Res Clin Anaesthesiol. 2005;19:247–68.CrossRefPubMedGoogle Scholar
  17. 17.
    Zink W, Graf BM. Benefit-risk assessment of ropivacaine in the management of postoperative pain. Drug Saf. 2004;27:1093–114.CrossRefPubMedGoogle Scholar
  18. 18.
    Fanelli G, Casati A, Beccaria P, Aldegheri G, Berti M, Tarantino F, et al. A double-blind comparison of ropivacaine, bupivacaine, and mepivacaine during sciatic and femoral nerve blockade. Anesth Analg. 1998;87:597–600.PubMedGoogle Scholar
  19. 19.
    Camorcia M, Capogna G, Columb MO. Minimum local analgesic doses of ropivacaine, levobupivacaine, and bupivacaine for intrathecal labor analgesia. Anesthesiology. 2005;102:646–50.CrossRefPubMedGoogle Scholar
  20. 20.
    Weber A, Fournier R, Van Gessel E, Riand N, Gamulin Z. Epinephrine does not prolong the analgesia of 20 mL ropivacaine 0.5% or 0.2% in a femoral three-in-one block. Anesth Analg. 2001;93:1327–31.CrossRefPubMedGoogle Scholar
  21. 21.
    Kirksey MA, Haskins SC, Cheng J, Liu SS. Local anesthetic peripheral nerve block adjuvants for prolongation of analgesia: a systematic qualitative review. PLoS One. 2015;10(9):e0137312.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Williams BA, Butt MT, Zeller JR, Coffee S, Pippi MA. Multimodal perineural analgesia with combined bupivacaine-clonidine-buprenorphine-dexamethasone: safe in vivo and chemically compatible in solution. Pain Med. 2015;16(1):186–98.CrossRefPubMedGoogle Scholar
  23. 23.
    Buckenmaier CC III, Bleckner LL. Anaesthetic agents for advanced regional anaesthesia: a North American perspective. Drugs. 2005;65:745–59.CrossRefPubMedGoogle Scholar
  24. 24.
    Bernards CM, Carpenter RL, Kenter ME, Brown DL, Rupp SM, Thompson GE. Effect of epinephrine on central nervous system and cardiovascular system toxicity of bupivacaine in pigs. Anesthesiology. 1989;71:711–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Butterworth JFT, Strichartz GR. The alpha 2-adrenergic agonists clonidine and guanfacine produce tonic and phasic block of conduction in rat sciatic nerve fibers. Anesth Analg. 1993;76:295–301.PubMedGoogle Scholar
  26. 26.
    Kopacz DJ, Bernards CM. Effect of clonidine on lidocaine clearance in vivo: a microdialysis study in humans. Anesthesiology. 2001;95(6):1371.CrossRefPubMedGoogle Scholar
  27. 27.
    Ota K, Namiki A, Iwasaki H, Takahashi I. Dose-related prolongation of tetracaine spinal anesthesia by oral clonidine in humans. Anesth Analg. 1994;79:1121–5.PubMedGoogle Scholar
  28. 28.
    Pöpping DM, Elia N, Marret E, Wenk M, Tramèr MR. Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocks: a meta-analysis of randomized trials. Anesthesiology. 2009;111(2):406–15.CrossRefPubMedGoogle Scholar
  29. 29.
    Abdallah FW, Brull R. Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: a systematic review and meta-analysis. Br J Anaesth. 2013;110(6):915–25.CrossRefPubMedGoogle Scholar
  30. 30.
    Agarwal S, Aggarwal R, Gupta P. Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block. J Anaesthesiol Clin Pharmacol. 2014;30(1):36–40.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Fritsch G, Danninger T, Allerberger K, Tsodikov A, Felder TK, Kapeller M, Gerner P, Brummett CM. Dexmedetomidine added to ropivacaine extends the duration of interscalene brachial plexus blocks for elective shoulder surgery when compared with ropivacaine alone: a single-center, prospective, triple-blind, randomized controlled trial. Reg Anesth Pain Med. 2014;39(1):37–47.CrossRefPubMedGoogle Scholar
  32. 32.
    Zhang X, Wang D, Shi M, Luo Y. Efficacy and safety of dexmedetomidine as an adjuvant in epidural analgesia and anesthesia: a systematic review and meta-analysis of randomized controlled trials. Clin Drug Investig. 2017;37(4):343–54.CrossRefPubMedGoogle Scholar
  33. 33.
    Liu S, Chiu AA, Carpenter RL, Mulroy MF, Allen HW, Neal JM, et al. Fentanyl prolongs lidocaine spinal anesthesia without prolonging recovery. Anesth Analg. 1995;80:730–4.PubMedGoogle Scholar
  34. 34.
    Mulroy MF, Larkin KL, Siddiqui A. Intrathecal fentanyl-induced pruritus is more severe in combination with procaine than with lidocaine or bupivacaine. Reg Anesth Pain Med. 2001;26:252–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Nishikawa K, Kanaya N, Nakayama M, Igarashi M, Tsunoda K, Namiki A. Fentanyl improves analgesia but prolongs the onset of axillary brachial plexus block by peripheral mechanism. Anesth Analg. 2000;91:384–7.PubMedGoogle Scholar
  36. 36.
    Van de Velde M, Teunkens A, Hanssens M, Vandermeersch E, Verhaeghe J. Intrathecal sufentanil and fetal heart rate abnormalities: a double-blind, double placebo-controlled trial comparing two forms of combined spinal epidural analgesia with epidural analgesia in labor. Anesth Analg. 2004;98:1153–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Williams BA, Hough KA, Tsui BY, Ibinson JW, Gold MS, Gebhart GF. Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine. Reg Anesth Pain Med. 2011;36(3):225–30.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    An K, Elkassabany NM, Liu J. Dexamethasone as adjuvant to bupivacaine prolongs the duration of thermal antinociception and prevents bupivacaine-induced rebound hyperalgesia via regional mechanism in a mouse sciatic nerve block model. PLoS One. 2015;10(4):e0123459.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Grant SA. The Holy Grail: long-acting local anaesthetics and liposomes. Best Pract Res Clin Anaesthesiol. 2002;16:345–52.CrossRefPubMedGoogle Scholar
  40. 40.
    Ma J, Zhang W, Yao S. Liposomal bupivacaine infiltration versus femoral nerve block for pain control in total knee arthroplasty: a systematic review and meta-analysis. Int J Surg. 2016;36(Pt A):44–55.CrossRefPubMedGoogle Scholar
  41. 41.
    Cheney FW, Domino KB, Caplan RA, Posner KL. Nerve injury associated with anesthesia: a closed claims analysis. Anesthesiology. 1999;90:1062–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Auroy Y, Benhamou D, Bargues L, Ecoffey C, Falissard B, Mercier FJ, et al. Major complications of regional anesthesia in France: the SOS Regional Anesthesia Hotline Service. Anesthesiology. 2002;97:1274–80.CrossRefPubMedGoogle Scholar
  43. 43.
    Capdevila X, Bringuier S, Borgeat A. Infectious risk of continuous peripheral nerve blocks. Anesthesiology. 2009;110:182–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Popping DM, Zahn PK, Van Aken HK, Dasch B, Boche R, Pogatzki-Zahn EM. Effectiveness and safety of postoperative pain management: a survey of 18 925 consecutive patients between 1998 and 2006 (2nd revision): a database analysis of prospectively raised data. Br J Anaesth. 2008;101:832–40.CrossRefPubMedGoogle Scholar
  45. 45.
    Neuburger M, Buttner J, Blumenthal S, Breitbarth J, Borgeat A. Inflammation and infection complications of 2285 perineural catheters: a prospective study. Acta Anaesthesiol Scand. 2007;51:108–14.CrossRefPubMedGoogle Scholar
  46. 46.
    Horlocker TT. Complications of spinal and epidural anesthesia. Anesthesiol Clin North America. 2000;18:461–85.CrossRefPubMedGoogle Scholar
  47. 47.
    Horlocker TT, McGregor DG, Matsushige DK, Schroeder DR, Besse JA. A retrospective review of 4767 consecutive spinal anesthetics: central nervous system complications. Perioperative Outcomes Group. Anesth Analg. 1997;84:578–84.CrossRefPubMedGoogle Scholar
  48. 48.
    Lee LA, Posner KL, Domino KB, Caplan RA, Cheney FW. Injuries associated with regional anesthesia in the 1980s and 1990s: a closed claims analysis. Anesthesiology. 2004;101:143–52.CrossRefPubMedGoogle Scholar
  49. 49.
    Ben-David B. Complications of regional anesthesia: an overview. Anesthesiol Clin North America. 2002;20:665–7. (ix).CrossRefPubMedGoogle Scholar
  50. 50.
    Capdevila X, Pirat P, Bringuier S, Gaertner E, Singelyn F, Bernard N, et al. Continuous peripheral nerve blocks in hospital wards after orthopedic surgery: a multicenter prospective analysis of the quality of postoperative analgesia and complications in 1,416 patients. Anesthesiology. 2005;103:1035–45.CrossRefPubMedGoogle Scholar
  51. 51.
    Phillips OC, Ebner H, Nelson AT, Black MH. Neurologic complications following spinal anesthesia with lidocaine: a prospective review of 10,440 cases. Anesthesiology. 1969;30:284–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Drasner K. Local anesthetic systemic toxicity: a historical perspective. Reg Anesth Pain Med. 2010;35:162–6.CrossRefPubMedGoogle Scholar
  53. 53.
    Auroy Y, Narchi P, Messiah A, Litt L, Rouvier B, Samii K. Serious complications related to regional anesthesia: results of a prospective survey in France. Anesthesiology. 1997;87:479–86.CrossRefPubMedGoogle Scholar
  54. 54.
    Brown DL, Ransom DM, Hall JA, Leicht CH, Schroeder DR, Offord KP. Regional anesthesia and local anesthetic-induced systemic toxicity: seizure frequency and accompanying cardiovascular changes. Anesth Analg. 1995;81:321–8.PubMedGoogle Scholar
  55. 55.
    Bernards CM, Carpenter RL, Rupp SM, Brown DL, Morse BV, Morell RC, et al. Effect of midazolam and diazepam premedication on central nervous system and cardiovascular toxicity of bupivacaine in pigs. Anesthesiology. 1989;70:318–23.CrossRefPubMedGoogle Scholar
  56. 56.
    Mather LE, Copeland SE, Ladd LA. Acute toxicity of local anesthetics: underlying pharmacokinetic and pharmacodynamic concepts. Reg Anesth Pain Med. 2005;30:553–66.PubMedGoogle Scholar
  57. 57.
    Weinberg GL. Treatment of local anesthetic systemic toxicity (LAST). Reg Anesth Pain Med. 2010;35:188–93.CrossRefPubMedGoogle Scholar
  58. 58.
    Mulroy MF, Hejtmanek MR. Prevention of local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010;35:177–80.CrossRefPubMedGoogle Scholar
  59. 59.
    Kopp SL, Horlocker TT, Warner ME, Hebl JR, Vachon CA, Schroeder DR, et al. Cardiac arrest during neuraxial anesthesia: frequency and predisposing factors associated with survival. Anesth Analg. 2005;100:855–65.CrossRefPubMedGoogle Scholar
  60. 60.
    Kasten GW, Martin ST. Comparison of resuscitation of sheep and dogs after bupivacaine-induced cardiovascular collapse. Anesth Analg. 1986;65:1029–32.PubMedGoogle Scholar
  61. 61.
    Neal JM, Bernards CM, JFt B, Di Gregorio G, Drasner K, Hejtmanek MR, et al. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010;35:152–61.CrossRefPubMedGoogle Scholar
  62. 62.
    Chadwick HS. Toxicity and resuscitation in lidocaine- or bupivacaine-infused cats. Anesthesiology. 1985;63:385–90.CrossRefPubMedGoogle Scholar
  63. 63.
    Butterworth JF IV. Models and mechanisms of local anesthetic cardiac toxicity: a review. Reg Anesth Pain Med. 2010;35:167–76.CrossRefPubMedGoogle Scholar
  64. 64.
    Di Gregorio G, Neal JM, Rosenquist RW, Weinberg GL. Clinical presentation of local anesthetic systemic toxicity: a review of published cases, 1979 to 2009. Reg Anesth Pain Med. 2010;35:181–7.CrossRefPubMedGoogle Scholar
  65. 65.
    Freysz M, Beal JL, Timour Q, Bertrix L, Faucon G. Systemic toxicity of local anesthetics. Pharmacokinetic and pharmacodynamic factors. Ann Fr Anesth Reanim. 1988;7:181–8.CrossRefPubMedGoogle Scholar
  66. 66.
    Siegmund JB, Wilson JH, Imhoff TE. Amiodarone interaction with lidocaine. J Cardiovasc Pharmacol. 1993;21:513–5.CrossRefPubMedGoogle Scholar
  67. 67.
    Kuhnert BR, Zuspan KJ, Kuhnert PM, Syracuse CD, Brashear WT, Brown DE. Lack of influence of cimetidine on bupivacaine levels during parturition. Anesth Analg. 1987;66:986–90.PubMedGoogle Scholar
  68. 68.
    Mather LE, Runciman WB, Carapetis RJ, Ilsley AH, Upton RN. Hepatic and renal clearances of lidocaine in conscious and anesthetized sheep. Anesth Analg. 1986;65:943–9.CrossRefPubMedGoogle Scholar
  69. 69.
    Bax ND, Tucker GT, Lennard MS, Woods HF. The impairment of lignocaine clearance by propranolol – major contribution from enzyme inhibition. Br J Clin Pharmacol. 1985;19:597–603.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004;29:564–75. (discussion 24).PubMedGoogle Scholar
  71. 71.
    O’Donnell BD, Iohom G. An estimation of the minimum effective anesthetic volume of 2% lidocaine in ultrasound-guided axillary brachial plexus block. Anesthesiology. 2009;111:25–9.CrossRefPubMedGoogle Scholar
  72. 72.
    Baciarello M, Danelli G, Fanelli G. Real-time ultrasound visualization of intravascular injection of local anesthetic during a peripheral nerve block. Reg Anesth Pain Med. 2009;34:278–9.CrossRefPubMedGoogle Scholar
  73. 73.
    Neal JM, Bernards CM, Hadzic A, Hebl JR, Hogan QH, Horlocker TT, et al. ASRA practice advisory on neurologic complications in Regional Anesthesia and Pain Medicine. Reg Anesth Pain Med. 2008;33:404–15.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Sorenson EJ. Neurological injuries associated with regional anesthesia. Reg Anesth Pain Med. 2008;33:442–8.CrossRefPubMedGoogle Scholar
  75. 75.
    Welch MB, Brummett CM, Welch TD, Tremper KK, Shanks AM, Guglani P, et al. Perioperative peripheral nerve injuries: a retrospective study of 380,680 cases during a 10-year period at a single institution. Anesthesiology. 2009;111:490–7.CrossRefPubMedGoogle Scholar
  76. 76.
    Faccenda KA, Finucane BT. Complications of regional anaesthesia incidence and prevention. Drug Saf. 2001;24:413–42.CrossRefPubMedGoogle Scholar
  77. 77.
    Freedman JM, Li DK, Drasner K, Jaskela MC, Larsen B, Wi S. Transient neurologic symptoms after spinal anesthesia: an epidemiologic study of 1,863 patients. Anesthesiology. 1998;89:633–41.CrossRefPubMedGoogle Scholar
  78. 78.
    Pollock JE. Transient neurologic symptoms: etiology, risk factors, and management. Reg Anesth Pain Med. 2002;27(6):581.PubMedGoogle Scholar
  79. 79.
    Liu SS, McDonald SB. Current issues in spinal anesthesia. Anesthesiology. 2001;94:888–906.CrossRefPubMedGoogle Scholar
  80. 80.
    Zaric D, Pace NL. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst Rev. 2009;(2):CD003006.Google Scholar
  81. 81.
    Bigeleisen PE. Nerve puncture and apparent intraneural injection during ultrasound-guided axillary block does not invariably result in neurologic injury. Anesthesiology. 2006;105:779–83.CrossRefPubMedGoogle Scholar
  82. 82.
    Kapur E, Vuckovic I, Dilberovic F, Zaciragic A, Cosovic E, Divanovic KA, et al. Neurologic and histologic outcome after intraneural injections of lidocaine in canine sciatic nerves. Acta Anaesthesiol Scand. 2007;51:101–7.CrossRefPubMedGoogle Scholar
  83. 83.
    Choyce A, Chan VW, Middleton WJ, Knight PR, Peng P, McCartney CJ. What is the relationship between paresthesia and nerve stimulation for axillary brachial plexus block? Reg Anesth Pain Med. 2001;26:100–4.CrossRefPubMedGoogle Scholar
  84. 84.
    Perlas A, Niazi A, McCartney C, Chan V, Xu D, Abbas S. The sensitivity of motor response to nerve stimulation and paresthesia for nerve localization as evaluated by ultrasound. Reg Anesth Pain Med. 2006;31:445–50.CrossRefPubMedGoogle Scholar
  85. 85.
    Urmey WF, Stanton J. Inability to consistently elicit a motor response following sensory paresthesia during interscalene block administration. Anesthesiology. 2002;96:552–4.CrossRefPubMedGoogle Scholar
  86. 86.
    Bollini CA, Urmey WF, Vascello L, Cacheiro F. Relationship between evoked motor response and sensory paresthesia in interscalene brachial plexus block. Reg Anesth Pain Med. 2003;28:384–8.CrossRefPubMedGoogle Scholar
  87. 87.
    Liu SS, Ngeow JE, Yadeau JT. Ultrasound-guided regional anesthesia and analgesia: a qualitative systematic review. Reg Anesth Pain Med. 2009;34:47–59.CrossRefPubMedGoogle Scholar
  88. 88.
    Tripathi M, Nath SS, Gupta RK. Paraplegia after intracord injection during attempted epidural steroid injection in an awake-patient. Anesth Analg. 2005;101:1209–11.CrossRefPubMedGoogle Scholar
  89. 89.
    Tsui BC, Armstrong K. Can direct spinal cord injury occur without paresthesia? A report of delayed spinal cord injury after epidural placement in an awake patient. Anesth Analg. 2005;101(4):1212.CrossRefPubMedGoogle Scholar
  90. 90.
    Borgeat A, Aguirre J, Curt A. Case scenario: neurologic complication after continuous interscalene block. Anesthesiology. 2010;112:742–5.CrossRefPubMedGoogle Scholar
  91. 91.
    Hogan Q, Dotson R, Erickson S, Kettler R, Hogan K. Local anesthetic myotoxicity: a case and review. Anesthesiology. 1994;80:942–7.CrossRefPubMedGoogle Scholar
  92. 92.
    Zink W, Graf BM. Local anesthetic myotoxicity. Reg Anesth Pain Med. 2004;29:333–40.CrossRefPubMedGoogle Scholar
  93. 93.
    Zink W, Bohl JR, Hacke N, Sinner B, Martin E, Graf BM. The long term myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blocks. Anesth Analg. 2005;101:548–54.CrossRefPubMedGoogle Scholar
  94. 94.
    Zink W, Seif C, Bohl JR, Hacke N, Braun PM, Sinner B, et al. The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades. Anesth Analg. 2003;97:1173–9.CrossRefPubMedGoogle Scholar
  95. 95.
    Zink W, Missler G, Sinner B, Martin E, Fink RH, Graf BM. Differential effects of bupivacaine and ropivacaine enantiomers on intracellular Ca2+ regulation in murine skeletal muscle fibers. Anesthesiology. 2005;102:793–8.CrossRefPubMedGoogle Scholar
  96. 96.
    Irwin W, Fontaine E, Agnolucci L, Penzo D, Betto R, Bortolotto S, et al. Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem. 2002;277:12221–7.CrossRefPubMedGoogle Scholar
  97. 97.
    Zink W, Graf BM, Sinner B, Martin E, Fink RH, Kunst G. Differential effects of bupivacaine on intracellular Ca2+ regulation: potential mechanisms of its myotoxicity. Anesthesiology. 2002;97:710–6.CrossRefPubMedGoogle Scholar
  98. 98.
    Wakata N, Sugimoto H, Iguchi H, Nomoto N, Kinoshita M. Bupivacaine hydrochloride induces muscle fiber necrosis and hydroxyl radical formation-dimethyl sulphoxide reduces hydroxyl radical formation. Neurochem Res. 2001;26:841–4.CrossRefPubMedGoogle Scholar
  99. 99.
    Nouette-Gaulain K, Bellance N, Prevost B, Passerieux E, Pertuiset C, Galbes O, et al. Erythropoietin protects against local anesthetic myotoxicity during continuous regional analgesia. Anesthesiology. 2009;110:648–59.CrossRefPubMedGoogle Scholar
  100. 100.
    Sztark F, Malgat M, Dabadie P, Mazat JP. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics. Anesthesiology. 1998;88:1340–9.CrossRefPubMedGoogle Scholar
  101. 101.
    Nouette-Gaulain K, Sirvent P, Canal-Raffin M, Morau D, Malgat M, Molimard M, et al. Effects of intermittent femoral nerve injections of bupivacaine, levobupivacaine, and ropivacaine on mitochondrial energy metabolism and intracellular calcium homeostasis in rat psoas muscle. Anesthesiology. 2007;106:1026–34.CrossRefPubMedGoogle Scholar
  102. 102.
    Nouette-Gaulain K, Dadure C, Morau D, Pertuiset C, Galbes O, Hayot M, et al. Age-dependent bupivacaine-induced muscle toxicity during continuous peripheral nerve block in rats. Anesthesiology. 2009;111:1120–7.CrossRefPubMedGoogle Scholar
  103. 103.
    Bailie DS, Ellenbecker TS. Severe chondrolysis after shoulder arthroscopy: a case series. J Shoulder Elbow Surg. 2009;18:742–7.CrossRefPubMedGoogle Scholar
  104. 104.
    Chu CR, Izzo NJ, Papas NE, Fu FH. In vitro exposure to 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes. Arthroscopy. 2006;22:693–9.CrossRefPubMedGoogle Scholar
  105. 105.
    Rapley JH, Beavis RC, Barber FA. Glenohumeral chondrolysis after shoulder arthroscopy associated with continuous bupivacaine infusion. Arthroscopy. 2009;25:1367–73.CrossRefPubMedGoogle Scholar
  106. 106.
    Busfield BT, Romero DM. Pain pump use after shoulder arthroscopy as a cause of glenohumeral chondrolysis. Arthroscopy. 2009;25:647–52.CrossRefPubMedGoogle Scholar
  107. 107.
    Seshadri V, Coyle CH, Chu CR. Lidocaine potentiates the chondrotoxicity of methylprednisolone. Arthroscopy. 2009;25:337–47.CrossRefPubMedGoogle Scholar
  108. 108.
    Anz A, Smith MJ, Stoker A, Linville C, Markway H, Branson K, et al. The effect of bupivacaine and morphine in a coculture model of diarthrodial joints. Arthroscopy. 2009;25:225–31.CrossRefPubMedGoogle Scholar
  109. 109.
    Breu A, Rosenmeier K, Kujat R, Angele P, Zink W. The cytotoxicity of bupivacaine, ropivacaine, and mepivacaine on human chondrocytes and cartilage. Anesth Analg. 2013;117(2):514–22.CrossRefPubMedGoogle Scholar
  110. 110.
    Amsler E, Flahault A, Mathelier-Fusade P, Aractingi S. Evaluation of re-challenge in patients with suspected lidocaine allergy. Dermatology. 2004;208:109–11.CrossRefPubMedGoogle Scholar
  111. 111.
    Hein UR, Chantraine-Hess S, Worm M, Zuberbier T, Henz BM. Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol. 1999;79:139–42.CrossRefPubMedGoogle Scholar
  112. 112.
    Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010;35:64–101.CrossRefPubMedGoogle Scholar
  113. 113.
    Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK. Executive summary: regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010;35:102–5.CrossRefPubMedGoogle Scholar
  114. 114.
    Carp H, Bailey S. The association between meningitis and dural puncture in bacteremic rats. Anesthesiology. 1992;76:739–42.CrossRefPubMedGoogle Scholar
  115. 115.
    Heavner JE. Local anesthetics. Curr Opin Anaesthesiol. 2007;20:336–42.CrossRefPubMedGoogle Scholar
  116. 116.
    Hadzic A, Dilberovic F, Shah S, Kulenovic A, Kapur E, Zaciragic A, et al. Combination of intraneural injection and high injection pressure leads to fascicular injury and neurologic deficits in dogs. Reg Anesth Pain Med. 2004;29:417–23.CrossRefPubMedGoogle Scholar
  117. 117.
    Jankovic D, Wells C. Brachial plexus. In: Jankovic D, Wells C, editors. Regional nerve blocks. Berlin: Blackwell Science; 2001. p. 58–86.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Francesco Vetri
    • 1
  • Jose A. Aguirre
    • 2
  • Effrossyni G. Votta-Velis
    • 1
  • Alain Borgeat
    • 2
  1. 1.Department of AnesthesiologyUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Division of AnesthesiologyBalgrist University HospitalZurichSwitzerland

Personalised recommendations